Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism

Homovanillic acid (HVA) is a metabolite of dopamine, reflecting central dopamine metabolism, primarily situated in the striatum. Low HVA concentrations in the cerebrospinal fluid (CSF) may indicate metabolic deficiencies in the pathways of the biosynthesis or catabolism of dopamine. In this retrospe...

Full description

Saved in:
Bibliographic Details
Published in:European journal of paediatric neurology 2003, Vol.7 (1), p.31-37
Main Authors: Van Der Heyden, JC, Rotteveel, JJ, Wevers, RA
Format: Article
Language:English
Subjects:
Adolescent
Age Factors
Brain Diseases - cerebrospinal fluid
Brain Diseases - diagnostic imaging
Brain Diseases - metabolism
Cerebrospinal fluid
Child
Child, Preschool
Children
Dopamine - metabolism
Homovanillic Acid - cerebrospinal fluid
Homovanillic acid concentration
Humans
Infant
Infant, Newborn
Magnetic Resonance Imaging
Retrospective Studies
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Homovanillic acid (HVA) is a metabolite of dopamine, reflecting central dopamine metabolism, primarily situated in the striatum. Low HVA concentrations in the cerebrospinal fluid (CSF) may indicate metabolic deficiencies in the pathways of the biosynthesis or catabolism of dopamine. In this retrospective study, we investigated the clinical presentation of patients whose HVA concentration in the CSF had been determined routinely after spinal taps for a variety of clinical reasons. A decrease of HVA concentration in the CSF, due to a defect in the biosynthesis or reuptake of dopamine, is expected to cause extrapyramidal features. However, we found a remarkable variability in the clinical symptoms. Similarly, a decreased HVA concentration in the CSF failed to coincide with specific abnormalities at neuroimaging. In view of the diversity of the clinical presentation and in the absence of specific enzyme deficiencies, a decrease of HVA may be due to dysfunction of dopamine neurons, not resulting in specific extrapyramidal symptoms. Thus, with the exception of diseases associated with a specific enzyme deficiency in the metabolic pathways involving dopamine, a decrease of HVA concentration in the CSF is mainly a secondary or epiphenomenon in a variety of clinical conditions.
ISSN:1090-3798
1532-2130
DOI:10.1016/S1090-3798(02)00137-X